B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome

被引:88
作者
Nezos, Adrianos [1 ]
Papageorgiou, Aristea [2 ]
Fragoulis, George [2 ]
Ioakeimidis, Dimitrios [3 ]
Koutsilieris, Michael [1 ]
Tzioufas, Athanasios G. [2 ]
Moutsopoulos, Haralampos M. [2 ]
Voulgarelis, Michael [2 ]
Mavragani, Clio P. [1 ]
机构
[1] Univ Athens, Sch Med, Dept Physiol, GR-11527 Athens, Greece
[2] Univ Athens, Sch Med, Dept Pathophysiol, GR-11527 Athens, Greece
[3] Gen Hosp Athens G Gennimatas, Dept Rheumatol, Athens, Greece
关键词
B-lymphocyte activator factor (BAFF); Lymphoma; Primary Sjogren's syndrome (SS); Single nucleotide polymorphisms (SNPs); Genetics; NON-HODGKIN-LYMPHOMA; CHRONIC LYMPHOCYTIC-LEUKEMIA; MALIGNANT-LYMPHOMA; BAFF LEVELS; RISK; EXPRESSION; AUTOIMMUNITY; POLYMORPHISM; DISORDERS; TNF;
D O I
10.1016/j.jaut.2013.04.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Primary Sjogren's syndrome (pSS) is complicated by B-cell lymphoma in 5-10% of patients. Several clinical and serological features are proposed as adverse predictors for such complication and define a high risk pSS phenotype. We aimed to explore whether previously described polymorphisms of the B-cell activating factor (BAFF) could be related to pSS-related lymphomagenesis. Five single nucleotide polymorphisms (SNPs) of the BAFF gene (rs1224141, rs12583006, rs9514828, rs1041569 and the rs9514827) were evaluated in 111 low risk pSS patients (type II), 82 high risk/lymphoma patients (type I) and 137 healthy controls (HC) by PCR-based assays. The classification of pSS patients into types I and II was based on the presence or absence of risk factors or lymphoma development, respectively. Genotype and haplotype analysis was performed for all variants in the pSS groups. Since the rs1041569 SNP was not in Hardy-Weinberg equilibrium in the HC group (p < 0.001), haplotype analysis was performed in the remaining four out of the five SNPs tested when comparisons with HC individuals were performed. The high risk pSS group was characterized by higher frequency of the minor T allele of the rs9514828 BAFF polymorphism compared to HC. Compared to the low risk pSS patients but not the HC, the high risk pSS group exhibited lower frequencies of the AA genotype of the rs12583006 polymorphism as well as the TACAC and TACC haplotypes and higher frequency of the TTTC haplotype. The low risk pSS group exhibited higher frequency of the minor A allele and AA genotype of the rs12583006 Variant compared to HC. Both pSS groups were characterized by increased frequency of the haplotype TATT and GTTC and decreased frequency of the TTCT when compared to HC. Taken together, these findings suggest the implication of the host's genetic background in pSS-related lymphomagenesis. The interaction of pSS-related BAFF gene haplotypes together with distinct BAFF genetic variants appears to contribute to this complication. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:89 / 98
页数:10
相关论文
共 42 条
[1]   The expression of BAFF in the muscles of patients with dermatomyositis [J].
Baek, Ahmi ;
Park, Hyung Jun ;
Na, Sang-Jun ;
Shim, Dong Suk ;
Moon, Joon-Shik ;
Yang, Young ;
Choi, Young-Chul .
JOURNAL OF NEUROIMMUNOLOGY, 2012, 249 (1-2) :96-100
[2]   TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma [J].
Batten, M ;
Fletcher, C ;
Ng, LG ;
Groom, J ;
Wheway, J ;
Laâbi, Y ;
Xin, XG ;
Schneider, P ;
Tschopp, J ;
Mackay, CR ;
Mackay, F .
JOURNAL OF IMMUNOLOGY, 2004, 172 (02) :812-822
[3]   B cells in Sjogren's syndrome: From pathophysiology to diagnosis and treatment [J].
Cornec, Divi ;
Devauchelle-Pensec, Valerie ;
Tobon, Gabriel J. ;
Pers, Jacques-Olivier ;
Jousse-Joulin, Sandrine ;
Saraux, Alain .
JOURNAL OF AUTOIMMUNITY, 2012, 39 (03) :161-167
[4]   Polymorphism of the tumour necrosis factor-alpha and lymphotoxin-alpha genes in chronic lymphocytic leukaemia [J].
Demeter, J ;
Porzsolt, F ;
Ramisch, S ;
Schmidt, D ;
Schmid, M ;
Messer, G .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (01) :107-112
[5]   B cell activator factor and a proliferation-inducing ligand at the cross-road of chronic lymphocytic leukemia and autoimmunity [J].
Ferrer, Gerardo ;
Hodgson, Kate ;
Montserrat, Emili ;
Moreno, Carol .
LEUKEMIA & LYMPHOMA, 2009, 50 (07) :1075-1082
[6]   No evidence for an association between the-871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjogren's syndrome [J].
Gottenberg, JE ;
Sellam, J ;
Ittah, M ;
Lavie, F ;
Proust, A ;
Zouali, H ;
Sordet, C ;
Sibilia, J ;
Kimberly, RP ;
Mariette, X ;
Miceli-Richard, C .
ARTHRITIS RESEARCH & THERAPY, 2006, 8 (01)
[7]   A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling [J].
Hildebrand, Joanne M. ;
Luo, Zhenghua ;
Manske, Michelle K. ;
Price-Troska, Tammy ;
Ziesmer, Steven C. ;
Lin, Wai ;
Hostager, Bruce S. ;
Slager, Susan L. ;
Witzig, Thomas E. ;
Ansell, Stephen M. ;
Cerhan, James R. ;
Bishop, Gail A. ;
Novak, Anne J. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 207 (12) :2569-2579
[8]   Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome [J].
Ioannidis, JPA ;
Vassiliou, VA ;
Moutsopoulos, HM .
ARTHRITIS AND RHEUMATISM, 2002, 46 (03) :741-747
[9]   Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcome [J].
Juszczynski, P ;
Kalinka, E ;
Bienvenu, J ;
Woszczek, G ;
Borowiec, M ;
Robak, T ;
Kowalski, M ;
Lech-Maranda, E ;
Baseggio, L ;
Coiffier, B ;
Salles, G ;
Warzocha, K .
BLOOD, 2002, 100 (08) :3037-3040
[10]   Analysis on the association of human BLYS (BAFF TNFSF13B) polymorphisms with systemic lupus erythematosus and rheumatoid arthritis [J].
Kawasaki, A ;
Tsuchiya, N ;
Fukazawa, T ;
Hashimoto, H ;
Tokunaga, K .
GENES AND IMMUNITY, 2002, 3 (07) :424-429